Article Text
Therapeutics/Prevention
Randomised controlled trial
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches
Statistics from Altmetric.com
Footnotes
Twitter Follow Anne Corbett at @DrAnneCorbett
Funding NIHR, Maudsley Biomedical Research Unit for Dementia.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.